1. Lila

    herpes vaccine developers skirting FDA oversight

    In what has been referred to as an effort to limit and/or test the U.S. Food and Drug Administration's (FDA) regulatory power, an investigational vaccine for herpes is being tested on the Caribbean island of St. Kitts without FDA or institutional review board approval. Clinical testing on the...